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Abstract
Many questions in Data Science are fundamentally causal in that our objective is to learn
the effect of some exposure, randomized or not, on an outcome interest. Even studies that
are seemingly non-causal, such as those with the goal of prediction or prevalence estimation,
have causal elements, including differential censoring or measurement. As a result, we, as Data
Scientists, need to consider the underlying causal mechanisms that gave rise to the data, rather
than simply the pattern or association observed in those data. In this work, we review the
“Causal Roadmap” of Petersen and van der Laan (2014) to provide an introduction to some key
concepts in causal inference. Similar to other causal frameworks, the steps of the Roadmap
include clearly stating the scientific question, defining of the causal model, translating the
scientific question into a causal parameter, assessing the assumptions needed to express the
causal parameter as a statistical estimand, implementation of statistical estimators including
parametric and semi-parametric methods, and interpretation of our findings. We believe that
using such a framework in Data Science will help to ensure that our statistical analyses are
guided by the scientific question driving our research, while avoiding over-interpreting our
results. We focus on the effect of an exposure occurring at a single time point and highlight
the use of targeted maximum likelihood estimation (TMLE) with Super Learner.
Key words: Causal inference; Directed acyclic graphs (DAGs); Observational studies; Structural
causal models; Targeted learning; argeted maximum likelihood estimation (TMLE)
1 Introduction
Recently, Herna´n et al. (2018) classified Data Science into three tasks: description, prediction, and
causal inference. The first two fall firmly in the realm of statistical inference in that they are purely
data-driven tasks, while the last requires something more than the observed data alone (Pearl
et al., 2016). Consider, for example, the target population of HIV-infected women of child-bearing
age (15-49 years old) in East Africa. After obtaining measurements on sample of women from this
population, we could provide some basic descriptive statistics on demographic and clinical variables,
such as age, education, use of antiretroviral therapy, pregnancy, and viral suppression, defined as
plasma HIV RNA ¡500 copies/mL. Likewise, we could use these variables to build a predictor of viral
suppression. This predictor could rely on parametric logistic regression or more advanced machine
learning algorithms, such as Super Learner (van der Laan et al., 2007; Petersen et al., 2015).
Now consider the potential impact of pregnancy on clinical outcomes in this population. While
optimizing virologic outcomes is essential to preventing mother-to-child-transmission of HIV, the
prenatal period could plausibly disrupt or enhance HIV care for a pregnant woman (Joint United
Nations Programme on HIV/AIDS (UNAIDS), 2014). We can then ask, ”what is the effect of
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pregnancy on HIV RNA viral suppression among HIV-positive women of child-bearing age in East
Africa?”. While the exposure of pregnancy is not a traditional treatment as commonly considered in
a randomized trial, this question is still causal in that we are asking about the outcomes of patients
under two different conditions and to answer this question, we must go beyond the observed data
set.
In particular, causal inference requires an a-priori specified set of, often untestable, assumptions
about the data generating mechanism. Once we posit a causal model, often encoded in the language
of causal graphs, we can express our scientific question in terms of a causal quantity. Under explicit
assumptions, we can then translate that causal quantity into a statistical estimand, a function
of the observed data distribution. This translation, called identifiability, is not guaranteed, as it
depends on the underlying scientific question, the structure of the causal model, and the observed
data. Lack of identifiability, however, provides us guidance on further data collection efforts and
the additional assumptions needed for such translation. Altogether we obtain a statistical estimand
that as closely as possible matches the underlying scientific question and thereby ensures that our
objective is driving the statistical analysis, as opposed to letting the statistical analysis determine
the question asked and answered (Petersen and van der Laan, 2014; Herna´n et al., 2008). Once the
estimand has been specified, we return to realm of statistics and the purely data-driven exercises of
point estimation, hypothesis testing, and creating 95% confidence intervals. Interpretation of the
resulting values, however, requires us again to consider our causal assumptions.
In this primer, we review the Causal Roadmap of Petersen and van der Laan (2014) to (1)
specify the scientific question; (2) build an accurate causal model of our knowledge; (3) define the
target causal quantity; (4) link the observed data to the causal model; (5) assess identifiability;
(6) estimate the resulting statistical parameter; and (7) appropriately interpret the results. This
Roadmap borrows the general logic from Descartes’s Scientific Method (Descartes, 1637) and shares
a common flow of other causal frameworks (Neyman, 1923; Rubin, 1974; Holland, 1986; Robins,
1986; Rubin, 1990; Spirtes et al., 1993; Pearl, 2000; Little and Rubin, 2000; Dawid, 2000; Heckman
and Vytlacil, 2007; Robins and Herna´n, 2009; van der Laan and Rose, 2011; Richardson and Robins,
2013; Herna´n and Robins, 2016). In particular, all approaches demand a clear statement of the
research objective, including the target population and interventions of interest (Herna´n, 2018;
Ahern, 2018). All approaches also provide guidance for conducting a statistical analysis that best
answers the motivating question. Unlike some of the other frameworks, however, the Roadmap
emphasizes the use of non-parametric or semi-parametric statistical methods, such as targeted
maximum likelihood estimation (TMLE), to avoid unwarranted parametric assumptions and harness
recent advances in machine learning. As a result this framework has sometimes been called the
Targeted Learning Roadmap (van der Laan and Rose, 2011; Tran et al., 2016; Kreif et al., 2017).
2 The Roadmap for Causal Inference
2.1 Specify the Scientific Question
The first step is to specify our scientific question. This helps frame our objective in a more detailed
way, while incorporating knowledge about the study. In particular, we need to specify the target
population, the exposure, and the outcome of interest. As our running example, we ask, what is the
effect of becoming pregnant on HIV RNA viral suppression (<500 copies/mL) among HIV-positive
women of child-bearing age (15-49 years) in East Africa?
This question provides a clear definition of the study variables and objective of our research.
It also makes explicit that the study only makes claims about the effect of a specific exposure,
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outcome, and target population. Any claims outside this context, such as a different exposure,
outcome, or target population, represent distinct questions and would require going through the
Roadmap again from the start. The temporal cues present in the research question are of particular
importance. They represent the putative cause, here pregnancy, and effect of interest, here viral
suppression. The temporal cues, together with background knowledge, are frequently used as a
basis for specifying the causal model, our next step.
2.2 Specify the Causal Model
One of the appealing features of causal modeling, and perhaps the reason behind its success, is the
rich and flexible language for encoding mechanisms underlying a data generating process. Here,
we focus on Pearl (2000)’s structural causal models, which unify causal graphs and structural
equations (Pearl, 1988; Goldberger, 1972; Duncan, 1975). Structural causal models formalize our
knowledge, however limited, of the study, including the relationships between variables and the role
of unmeasured factors.
Let us consider again our running example of the impact of pregnancy on HIV viral suppression
among women in East Africa. Let W1 denote the set of baseline demographic covariates, such as
age, marital status, and education level, and W2 denote the set of pre-exposure HIV care variables,
such as prior use of antiretroviral therapy. The exposure A is a binary variable indicating that the
woman is known to be pregnant, and the outcome Y is a binary indicator of currently suppressing
HIV viral replication: <500 copies per mL. These constitute the set of endogenous variables, which
are denoted X = {W1,W2, A, Y } and are essential to answering the research question.
Each endogenous variable is associated with a latent background factor UW1 , UW2 , UA, and UY ,
respectively. The set of background factors are called exogenous variables and denoted U =
(UW1 , UW2 , UA, UY ). These variables account for all other unobserved sources that might influence
each of the endogenous variables and can share common components. In our example, unmeasured
background factors U might include socioeconomic status, the date of HIV infection, the date of
conception, her partner’s HIV status, and her genetic profile.
Causal Graphs: The “causal story” of the data can be conveyed using the language of graphs
(Pearl, 2000; Pearl et al., 2016). Graphical models consist of a set of nodes representing the variables,
and a set of directed or undirected edges connecting these nodes. Two nodes are adjacent if there
exists an edge between them, and a path between two nodes A and B is a sequence of adjacent
nodes starting from A and ending in B. If an edge is directed from node A to node B, then A is the
parent of B, and B is the child of A. More generally, for any path starting from node A, the set of
nodes included in this path are descendants of A, and A is the ancestor of all the nodes included
in this set.
Here, we are interested in Directed Acyclic Graphs (DAGs), which are fully directed graphs with
no path from a given node to itself. DAGs provide a mechanism to explicitly encode our causal
assumptions about the underlying data generating process. Specifically, a variable A is a direct
cause of another variable B, if B is the child of A in the causal graph. Also, a variable A is a cause
of another variable B, if B is a descendant of A in the causal graph (Pearl, 2000).
To illustrate, Figure 1(a) provides a DAG corresponding to our running example. From this
graph, we can make the following statements:
1. Baseline demographics W1 may affect a woman’s pre-exposure HIV care W2, her pregnancy
status A, and her HIV viral suppression status Y .
2. Prior care W2 may affect her pregnancy status A, and her HIV viral suppression status Y .
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U
Y
W2
(a) (b)
Figure 1: Encoding the underlying causal mechanisms with graphical models. Shaded nodes repre-
sent exogenous variables, and unshaded nodes are endogenous variables. Directed edges represent a
direct cause between a pair of variables. Double-headed dashed arrows represent potential correla-
tion between the exogenous factors (i.e., unmeasured common causes of the endogenous variables).
In (a) we give a directed acyclic graph (DAG) with a single node U representing all the common
unmeasured sources. In (b) we provide an alternative representation to make explicit the relation-
ships between the unmeasured background factors U = {UW1 , UW2 , UA, UY } and each endogenous
variable.
3. Being pregnant A may affect her HIV viral suppression status Y .
4. Unmeasured factors U = (UW1 , UW2 , UA, UY ) may affect a woman’s baseline characteristics,
her prior care, her fertility, and her suppression outcome.
In Figure 1(a), a single node U represents all the common, unmeasured factors that could impact
the pre-exposure covariates, the exposure, and the outcome. In an alternative representation in
Figure 1(b), we have explicitly shown each exogenous variable (UW1 , UW2 , UA, UY ) as a separate
node and as parent to its corresponding endogenous variable (W1,W2, A, Y ), respectively. In the
latter, dashed double-headed arrows denote correlation between the exogenous factors.
Both representations make explicit that there could be unmeasured common causes of the co-
variates W = (W1,W2) and the exposure A, the exposure A and the outcome Y , and the covariates
W and the outcome Y . In other words, there is measured and unmeasured confounding present in
this study. Altogether, we have avoided many unsubstantiated assumptions about the causal rela-
tionships between the variables. This causal model is, thus, non-parametric beyond the assumed
time-ordering between variables.
Causal graphs can be extended to accommodate more complicated data structures. Suppose, for
example, plasma HIV RNA viral levels are missing for some women in our population of interest. We
could modify our causal model to account for incomplete measurement (Robins et al., 2000, 1994;
Scharfstein et al., 1999; Daniel et al., 2012; Mohan et al., 2013; Balzer et al., 2017). Specifically, we
redefine the exposure node for pregnancy as A1 and introduce a new intervention node A2 defined
as indicator that her viral load is measured. The resulting causal graph is represented in Figure 2.
We refer the readers to Mohan et al. (2013) for detailed discussion of formulating a causal model
for the missingness mechanism and to Petersen et al. (2017) for a real world application handling
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missingness on both HIV status and viral loads (Balzer et al., 2017). For the remainder of the
primer, we assume, for simplicity, there are no missing data and Figure 1 holds. As discussed in
the Appendix, other extensions can also be made to account for common complexities, such as
longitudinal data and effect mediation.
A1
W1
W2
U
A2
Y
Figure 2: Causal graph extending the running example to account for missingness on the outcome.
Along the baseline demographic W1, clinical covariates W2, and suppression outcome Y , we now
have two intervention nodes A1 for pregnancy status and A2 for measurement of plasma HIV RNA
level.
In the subsequent steps, we discuss how altering the causal graph, particularly by removing
edges, is equivalent to making additional assumptions about the data generating process. Before
doing so, however, we present the causal model in its structural form.
Non-Parametric Structural Equations: Structural causal models also encode information
about the data generating process with a set of non-parametric equations. Like the causal graph,
these equations describe how “nature” would deterministically generate the variables in our study
(Pearl, 2000; Pearl et al., 2016). Use of the equations can be preferable in longitudinal settings
when causal graphs can become unwieldily.
Formally, we define a structural causal model, denotedM∗, by the set of exogenous variables U ,
the set of endogenous variables X, and a set of functions F that deterministically assign a value to
each variable in X, given as input the values of other variables in X and U . These non-parametric
structural equations allow us to expand our definition of causal assumptions (Pearl, 2000; Pearl
et al., 2016). Variable A is considered to be a direct cause of variable B, if A appears in the
function assigning a value to B. Variable A is also a cause of variable B, if A is direct cause of B
or any causes of B.
In our HIV viral suppression example, the corresponding structural equations are
W1 = fW1(UW1)
W2 = fW2(W1, UW2) (1)
A = fA(W1,W2, UA)
Y = fY (W1,W2, A, UY )
where the set of functions F = {fW1 , fW2 , fA, fY } encode the mechanism deterministically generating
the value of each endogenous variable. The exogenous variables U = {UW1 , UW2 , UA, UY } have a
joint probability distribution PU and coupled with the set of structural equations F give rise to a
particular data generating process that is compatible with the causal assumptions implied by M∗.
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In our example, for a given probability distribution PU and set of structural equations F , the
structural causal model M∗ describes the following data generating process. For each woman,
1. Draw the exogenous variables U from the joint probability distribution PU . Intuitively, when
we sample a woman from the population, we obtain all the unmeasured variables that could
influence her baseline covariates, prior care, pregnancy status, and suppression outcome.
2. Generate demographic covariates W1 deterministically using UW1 as input to the function
fW1 ; the demographic covariates include her age, marital status, education attained, and
socioeconomic status.
3. Generate past HIV care covariates W2 deterministically using UW2 and the woman’s demo-
graphic covariates W1 as input to the function fW2 ; the measured clinical factors include
history of antiretroviral therapy use and prior HIV suppression status.
4. Generate pregnancy status A deterministically using UA, W1, and W2 as inputs to function
fA. Recall A is an indicator equaling 1 if the woman is known to be pregnant and 0 otherwise.
5. Generate HIV suppression outcome Y deterministically using UY , W1, W2, and A as inputs
to function fY . Recall Y is an indicator equaling 1 if her HIV RNA viral level is less than 500
copies per mL and 0 otherwise.
It is important to note that the set of structural equations are non-parametric. In other words,
the explicit relationship between the system variables, as captured by the set of functions F , are
left unspecified. If knowledge is available regarding a relationship of interest, it can be readily
incorporated in the structural equations. For instance, in a two-armed randomized trial with equal
allocation probability, the function that assigns a value to the exposure variable A can be explicitly
encoded as A = fA(UA) = I(UA < 0.5), where I is an indicator function and UA assumed to be
drawn from a Uniform(0, 1).
2.3 Define the Target Causal Quantity
Once the causal model is specified, we may begin to ask questions of causal nature. The rationale
comes from the observation that the structural causal model M∗ is not restricted to the partic-
ular setting of our study, but can also describe the same system under changed conditions. The
structural equations are autonomous, which means that modifying one function does not change an-
other. Therefore, we can make targeted modifications to our causal model to evaluate hypothetical,
counterfactual scenarios that would otherwise never be realized, but correspond to our underlying
scientific question.
In our running example, we are interested in the effect of pregnancy on viral suppression. In the
original causal model (Figure 1 and Equation 1), a woman’s pregnancy status is determined by her
baseline demographics W1, prior care status W2, and unmeasured factors UA, such as contraceptive
use. However, our objective is to determine the probability of viral suppression if all women in
the target population were pregnant versus if the same women over the same time-frame were not
pregnant. The autonomy of the structural equations allows us to modify the way in which the
exposure, here pregnancy, is determined. In particular, we can intervene on the exposure A to
deterministically set A = 1 in one scenario, and then set A = 0 in another, while keeping the other
equations constant.
The post-intervention causal graph is given in Figure 3 and the structural equations become
W1 = fW1(UW1) W1 = fW1(UW1)
W2 = fW2(W1, UW2) W2 = fW2(W1, UW2)
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U
Y(a)
W2
Figure 3: Causal graph after intervention on the exposure, pregnancy status, to set A = a. Since
this is done deterministically and independently of other variables in the system, the only node
causing a change in A is the intervention node a ∈ {0, 1}.
A = 1 A = 0
Y (1) = fY (W1,W2, 1, UY ) Y (0) = fY (W1,W2, 0, UY )
These interventions generate counterfactual outcomes Y (a) for a ∈ {0, 1}, whose distribution is
denoted P∗. These causal quantities are indicators that a participant would have suppressed viral
replication, if possibly contrary to fact, her pregnancy status were A = a.
In this case, it is both physically impossible and unethical to design a randomized trial for
pregnancy. In other words, we cannot directly intervene on a woman’s pregnancy status. Likewise in
Figure 2, enforcing measurement of the outcome, which translates into setting A2 = 1, is impossible.
While neither intervention is plausible, we believe counterfactuals provide a language to express
many questions in Data Science in a mathematically tractable way. Nonetheless, we note that there
has been an lively debate about defining and interpreting analyses of variables on which one cannot
directly intervene (Pearl, 1995; Herna´n, 2005; van der Laan et al., 2005; Petersen and van der Laan,
2014; Herna´n and Robins, 2016).
Given the counterfactual outcomes and their distribution P∗, we can express our scientific ques-
tion as a mathematical quantity. One common choice is the Average Treatment Effect (ATE):
Ψ∗(P∗) := E∗[Y (1)− Y (0)], (2)
where the expectation is taken with respect to P∗. Since the causal model M∗ provides the set
of possible probability distributions for the exogenous and endogenous factors (U,X) and thus the
counterfactual outcomes (Y (1), Y (0)), Ψ∗ is a mapping from M∗ to the real numbers. The target
causal parameter Ψ∗(P∗) represents the difference in the expected counterfactual outcome if all
units in the target population were exposed and the expected counterfactual outcome if the same
units were not exposed. For the running example, Ψ∗(P∗) can be interpreted as the difference in the
counterfactual probability of viral suppression if all women in the target population were pregnant
versus if all women were not.
Before discussing how these causal quantities can be identified from the observed data dis-
tribution, we emphasize that for simplicity we have focused on a binary intervention, occurring
deterministically at a single time point. Scientific questions corresponding to categorical, continu-
ous, stochastic, and longitudinal exposures are also encompassed in this framework, but beyond the
scope of this primer and are briefly discussed in the Appendix. We also note that other summaries,
such as relative measures, the sample average effect, or marginal structural models, may better
capture the researcher’s scientific question.
7
2.4 Link the Observed Data to the Causal Model
Thus far, we have defined our scientific question, specified a structural causal modelM∗ to represent
our knowledge of the data generating process, intervened on that causal model to generate coun-
terfactual outcomes, and used these counterfactuals to express our scientific question as a causal
quantity. The next step is to provide an explicit link between the observed data and the specified
structural causal model.
Returning to our running example, suppose we have a simple random sample of N women from
our target population. On each woman, we measure her baseline demographics W1, prior HIV care
W2, pregnancy status A, and suppression outcome Y . These measurements constitute our observed
data for each woman in our sample: O = {W1,W2, A, Y }. Therefore, we have N independent,
identically distributed copies of O, which are drawn from some probability distribution P. Other
sampling schemes, such as case-control, are accommodated by this framework, but are beyond the
scope of this primer.
If we believe that our causal model accurately describes the data generating process, we can
assume that the observed data are generated by sampling repeatedly from a distribution compatible
with the structural causal model. In other words, the structural causal model M∗ provides a de-
scription of the study under existing conditions (i.e., the real world) and under specific intervention
(i.e., the counterfactual world). As a result, the observed outcome Y equals the counterfactual
outcome Y (a) when the observed exposure A equals the exposure of interest, a; this is commonly
called the consistency assumption.
In our example, all the endogenous variables are observed: X = O; therefore, we can write
P(O = o) =
∑
u
P∗(X = x|U = u)P∗(U = u), (3)
where an integral replaces the summation for continuous variables. This, however, might not always
be the case. Suppose, for example, we only measured demographics, pregnancy status, and viral
suppression, but failed to measure variables related to prior HIV care. Then the observed data
would be O = (W1, A, Y ) and are a subset of all the endogenous variables X. In either case, we
see that the structural causal modelM∗, defined as the collection of all possible joint distributions
of the exogenous and endogenous variables (U,X), implies the statistical model M, defined as
the collection of all possible joint distributions for the observed data O. The structural causal
model M∗ rarely implies restrictions on the resulting statistical model M, which is thereby often
non-parametric. An important exception is a completely randomized trial, where the unmeasured
factors determining the treatment assignment UA are independent of the others and results in a semi-
parametric statistical model. The D-separation criteria of Pearl (2000) can be used to evaluate what
statistical assumptions, if any, are implied by the causal model. The true observed data distribution
P is an element of the statistical model M.
2.5 Assessing Identifiability
In the previous section, we established a bridge between our structural causal model M∗ and
our statistical model M. However, we have not yet discussed the conditions under which causal
assumptions and observed data can be combined to answer causal questions. Structural causal
models provide one way to assess the assumptions needed to express our target causal quantity as
a statistical estimand, which is a well-defined function of the observed data distribution P.
Recall in Section 2.3 that we defined our target causal parameter as the average treatment effect
Ψ∗(P∗) = E∗[Y (1)−Y (0)]: the difference in the expected viral suppression status if all women were
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pregnant versus if none were. If given a causal model and its link to the observed data, the target
causal parameter can be expressed as a function of the observed data distribution P, then the causal
parameter is called identifiable. If not, we can still explicitly state and evaluate the assumptions
needed to render the target causal parameter identifiable from the observed data distribution.
One of the main tools for assessing identifiability of causal quantities is a set of criteria based on
causal graphs. In general, these criteria provide a systematic approach to identify an appropriate
adjustment set. Here, we focus on identifiability for the effect of a single intervention at one
time, sometimes called “point-treatment effects”. For these problems, we first present the back-
door criterion and the front-door criterion. For a detailed presentation of graphical methods for
assessing identifiability in causal graphs, the reader is referred to Pearl (2000); Pearl et al. (2016).
Formally, we say that a path is blocked if at least one variable in that path is conditioned on,
and we define a back-door path from a given node A as any path that contains an arrow into node A.
Then, given any pair of variables (A,B), where A occurs before B in a directed acyclic graph, a set
of variables C is said to satisfy the back-door criterion with respect to (A,B) if (1) the descendants
of A do not include any node in C, and (2) C blocks every back-door path from A to B . The
rationale behind this criterion is that, for C to be the appropriate adjustment set that isolates the
causal effect of A on B, we must block all spurious paths between A and B, and leave directed
paths from A to B unblocked. This criterion does not, however, cover all possible graph structures.
Alternatively, a set of variables C satisfies the front-door criterion with respect to a pair of
variables (A,B) if (1) all directed paths from A to B are blocked by C, (2) all paths from A to C
are blocked, and (3) all paths from C to B containing an arrow into C are blocked by A. We note that
the front-door criterion is more involved than its back-door counterpart, in the sense that it requires
more stringent conditions to hold for a given adjustment set to satisfy identifiability. In practice,
it is often the case that the back-door criterion is enough to identify the needed adjustment set,
especially in point-treatment settings. When the back-door criterion holds, the observed association
between the exposure and outcome can be attributed to the causal effect of interest, as opposed to
spurious sources of correlation.
In our running example, the set of baseline covariates W = (W1,W2) will satisfy the back-door
criterion with respect to the effect of pregnancy A on HIV viral suppression Y , if the following two
conditions hold:
1. No node in W is a descendant of A.
2. All back-door paths from A to Y are blocked by W .
Looking at the posited causal graph from Figure 1(a), we see that the first condition holds, but the
second is violated. There exists a back-door path from A to Y through the unmeasured background
factors U . Intuitively, the unmeasured common causes of pregnancy and HIV viral suppression
obstruct our isolation of the causal effect of interest and thus “confound” our analyses. Therefore,
our target causal quantity is not identifiable in the original causal model M∗.
Nonetheless, we can explicitly state and consider the plausibility of the causal assumptions
needed for identifiability. In particular, the following independence assumptions are sufficient to
satisfy the back-door criterion and thus identify the causal effect in this point-treatment setting.
1. There must not be any unmeasured common causes of the exposure and the outcome: UA |= UY
and,
(a) There must not be any unmeasured common causes of the exposure and the baseline
covariates: UA |= UW1 and UA |= UW2
or
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(b) There must not be any unmeasured common causes of the baseline covariates and the
outcome: UW1 |= UY and UW2 |= UY .
These criteria are reflected in the causal graphs shown in Figure 4. In the running example, assump-
tion 1.a states that there are no unmeasured common causes of pregnancy status and demographic or
clinical factors, while 1.b assumes that there are no unmeasured common causes of viral suppression
and demographic or clinical factors.
The independence assumptions in 1.a hold by design in a stratified, randomized trial, where the
unmeasured factors determining the exposure assignment are independent of all other unmeasured
factors. As a result, these independence assumptions (1.a and/or 1.b) are sometimes called the
randomization assumption and equivalently expressed as Y (a) |= A | W . These assumptions are also
referred to as “unconfoundedness”, “selection on observables”, and “conditional exchangeability”
(Robins, 1986).
A
W1
UA
U
Y
W2
(a)
A
W1
U
Y
UY
W2
(b)
Figure 4: Causal graphs corresponding the identifiability assumptions (1.a) and (1.b), respectively.
Here, we have explicitly shown that the unmeasured factors contributing to the exposure UA in (a)
and the outcome UY in (b) are independent of the others.
With these assumptions, we can express the distribution of counterfactual outcomes in terms of
the distribution of the observed data:
P∗(Y (a)) =
∑
w
P∗(Y (a)|W = w)P∗(W = w)
=
∑
w
P∗(Y (a)|A = a,W = w)P∗(W = w)
=
∑
w
P(Y |A = a,W = w)P(W = w)
where W = (W1,W2) denotes the pre-exposure covariates, including both demographic and clinical
factors, and where the summation generalizes to an integral for continuous covariates here and in
all subsequent expressions. The first equality is by the law of iterated expectations. The second
equality holds by the randomization assumption, and the final by the established link between the
causal and statistical model (Section 2.4).
Under these assumptions, we can express the average treatment effect Ψ∗(P∗) = E∗[Y (1)−Y (0)],
as a statistical estimand, often called the G-computation identifiability result (Robins, 1986):
Ψ(P) :=
∑
w
[
E(Y |A = 1,W = w)− E(Y |A = 0,W = w)]P(W = w) (4)
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Thus, our statistical target is the difference in the expected outcome, given the exposure and
covariates, and the expected outcome, given no exposure and covariates, averaged with respect
to the distribution of the baseline covariates W . In our example, Ψ(P) is the difference in the
probability of viral suppression, between pregnant and non-pregnant women with the same values
of the covariates, standardized with respect to the covariate distribution in the population.
The same quantity can be expressed in inverse probability weighting form:
Ψ(P) := E
[(
I(A = 1)
P(A = 1 | W ) −
I(A = 0)
P(A = 0 | W )
)
Y
]
(5)
The latter representation highlights an additional data support condition, known as positivity :
mina∈A P(A = a|W = w) > 0, for all w such that P(W = w) > 0.
Each exposure level of interest must occur with a positive probability within the strata of the
discrete-valued adjustment set W . This assumption is also called “overlap” and “the experimental
treatment assignment assumption”. We refer the reader to Petersen et al. (2012) for a discussion
of this assumption and approaches when it is theoretically or practically violated. For continuous
covariates, it is not straightforward to evaluate the positivity assumption. One commonly used
approach is to transform these continuous variables into categories or quantiles, and assess positivity
violations as with categorical variables (Cole and Herna´n, 2008; Messer et al., 2010).
Overall, the identifiability step is essential to specifying the needed adjustment set, and thereby
statistical estimand to link our causal effect of interest to some function of the observed data dis-
tribution. Above, we focused on a simple point-treatment setting with measured and unmeasured
confounding, but without mediation, biased sampling, or missing data. In more realistic settings,
there many other sources of association between our exposure and outcome, including selection bias,
direct and indirect effects, and the common statistical paradoxes of Berkson’s bias and Simpson’s
Paradox (Herna´n et al., 2004; Herna´ndez-Dı´az et al., 206). Furthermore, in the setting of longitu-
dinal exposures with time-dependent confounding, the needed adjustment set may not be intuitive
and the short-comings of traditional approaches become more pronounced (Robins, 1986; Robins
et al., 2000; Robins and Herna´n, 2009; Pearl et al., 2016). Indeed, methods to distinguish between
correlation and causation are crucial in the era of “Big Data”, where the number of variables is
growing with increasing volume, variety, and velocity (Rose, 2012; Marcus and Davis, 2014; Balzer
et al., 2016).
Nonetheless, it is important to note that specifying a causal model (Section 2.2) does not guar-
antee the identification of a causal effect. Causal frameworks do, however, provide insight into the
limitations and full extent of the questions that can be answered given the data at hand. They
further facilitate the discussion of modifications to the study design, the measurement additional
variables, and sensitivity analyses (Robins et al., 1999; Imai et al., 2010; VanderWeele and Arah,
2011; Dı´az and van der Laan, 2013a).
In fact, even if the causal effect is not identifiable (e.g., Figure 1), the Causal Roadmap still
provides us with a statistical estimand (e.g., Equation 4) that comes as close as possible to the
causal effect of interest given the limitations in the observed dataset. In the next sections, we
discuss estimation of this statistical parameter and use identifiability results, or lack there of, to
inform the strength of our interpretations.
2.6 Estimate the Target Statistical Parameters
Once the statistical model and estimand have been defined, the Causal Roadmap returns to tra-
ditional statistical inference to estimate functions of a given observed data distribution. Here, we
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focus on estimators based on the G-computation identifiability result Ψ(P). Popular methods for
estimation and inference for Ψ(P), which would equal the average treatment effect if the identifia-
bility assumptions held, include parametric G-computation, Inverse Probability Weighting (IPW),
and Targeted Maximum Likelihood Estimation (TMLE) (Robins, 1986; Horvitz and Thompson,
1952; Rosenbaum and Rubin, 1983; van der Laan and Rubin, 2006; van der Laan and Rose, 2011).
Below we briefly outline the implementation of each estimator and refer the reader to Petersen and
Balzer (2014) for worked R code for each algorithm. We emphasize that while each algorithm is
targeting a causally motivated statistical estimand, these algorithms are not directly estimating
causal effects, and therefore it is a misnomer to call them “causal estimators”.
Parametric G-computation is an algorithm that simply estimates the quantities needed to
calculate the statistical estimand defined in Equation (4) and then substitutes those quantities into
the G-computation formula (Robins, 1986; Taubman et al., 2009; Young et al., 2011; Westreich et al.,
2012; Zhang et al., 2018). As a result, this algorithm is sometimes called the simple substitution
estimator and is implemented with the following steps.
1. Regress the outcome on the exposure and covariate adjustment set to estimate the conditional
expectation E(Y |A,W ).
2. Based on the estimates from the Step 1, generate the predicted outcomes for each individual
in the sample while deterministically setting the value of the exposure to the levels of interest,
but keeping the covariates the same:
Eˆ(Yi|Ai = 1,Wi) and Eˆ(Yi|Ai = 0,Wi) for all observations i = 1, ..., N.
For a binary outcome this step is corresponds to generating the predicted probabilities Pˆ(Yi =
1|Ai = a,Wi) for exposure levels a ∈ {0, 1}.
3. Obtain a point estimate by taking a sample average of the difference in the predicted outcomes
from Step 2:
ΨˆGcomp(Pˆ) =
1
N
N∑
i=1
[
Eˆ(Yi|Ai = 1,Wi)− Eˆ(Yi|Ai = 0,Wi)
]
where Pˆ denotes the empirical distribution, which is the non-parametric maximum likeli-
hood estimator of the covariate distribution P(W ). The sample proportion is a simple non-
parametric estimator of P(W = w): 1
N
∑
i I(Wi = w).
Inverse Probability Weighting (IPW) is an estimator based on an alternative form of the G-
computation identifiability result defined in Equation (5) (Horvitz and Thompson, 1952; Rosenbaum
and Rubin, 1983; Robins et al., 2000; Bodnar et al., 2004; Cole and Herna´n, 2008). In this form,
the statistical estimand is a function of the conditional probability of being exposed, given the
adjustment covariates P(A = 1|W ), which is often called the propensity score (Rosenbaum and
Rubin, 1983). IPW controls for confounding by up-weighting rare exposure-covariate subgroups,
which have a small propensity score, and down-weighting more common subgroups, which have a
larger propensity score. The IPW estimator is implemented with the following steps.
1. Regress the exposure on the covariate adjustment set to estimate the propensity score P(A =
1|W ).
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2. Based on the estimates from Step 1, predict each individual’s probability of receiving her
observed exposure, given the adjustment covariates:
Pˆ(Ai|Wi) for all observations i = 1, ..., N.
3. Obtain a point estimate by taking the empirical mean of the outcome weighted by the inverse
of the conditional exposure probabilities:
ΨˆIPW (Pˆ) =
1
N
N∑
i=1
(
I(Ai = 1)
Pˆ(Ai = 1|Wi)
− I(Ai = 0)
Pˆ(Ai = 0|Wi)
)
Yi.
Thus, individuals who are exposed receive weight as one over the estimated propensity score
Pˆ(Ai = 1|Wi), while individuals who are not exposed receive weight as negative one over the
estimated probability of not being exposed, given the covariates Pˆ(Ai = 0|Wi).
The performance of the parametric G-computation depends on consistent estimation of the
conditional expectation of the outcome, given the exposure and covariates E(Y |A,W ), and the
performance of IPW relies on consistent estimation of the propensity score P(A = 1|W ). Tradi-
tionally, both estimators have relied on parametric regression models to estimate these quantities.
If sufficient background knowledge is available to support using such a regression, it should have
already been encoded in the causal model, yielding parametric structural equations in Section 2.2,
and can be incorporated during estimation.
However, in most real-world studies with a large number of covariates and potentially compli-
cated relationships, we usually do not have the knowledge support using such parametric regressions.
More often, our statistical model M for the set of possible distributions of the observed data is
non-parametric or semi-parametric (Section 2.4). Furthermore, we want to avoid introducing new
and unsubstantiated assumptions during estimation. Reliance on poorly specified parametric re-
gressions can result in biased point estimates and misleading inference (e.g., Benkeser et al. (2017);
Luque-Fernandez et al. (2018)). At the same time, non-parametric methods, such as stratification,
will break down due to sparsity. Here, recent advances in machine learning can help us estimate
E(Y |A,W ) and P(A = 1|W ) without introducing new assumptions.
Data-adaptive estimation or machine learning techniques can be used to effectively estimate
the nuisance parameters, which are the quantities needed to compute our statistical estimand:
E(Y |A,W ) and P(A = 1|W ). We focus our discussion on ensemble learning methods, which “stack”
or combine several prediction algorithms together and can be implemented as follows (Wolpert,
1992; Breiman, 1996).
First, we pre-specify a library of candidate algorithms, such as generalized linear models, splines,
random forests, neural networks, or support vector machines. We also define a measure of per-
formance through an appropriate loss function, such as the mean squared error or the negative
log-likelihood. Next, we randomly split the observed data into training and validation sets to as-
sess the performance of each algorithm in the library. We then fit each algorithm using only data
from the training set and predict the outcomes for the units in validation set. Each algorithm’s
performance is quantified by deviations, corresponding to the loss function, between the actual and
predicted outcomes for the units in the validation set. Repeating the process V times amounts to
performing V-fold cross-validation. We could then select the algorithm with the best performance,
corresponding to the smallest cross-validated risk estimate.
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This procedure, called Discrete Super Learner (van der Laan et al., 2007), effectively sets up
a competition between the algorithms specified in the library, and selects the one with the best
performance. It naturally follows then that Discrete Super Learner can only perform as well as the
best performing algorithm specified in its library. The full Super Learner algorithm improves upon
its discrete version by taking a weighted combination of the algorithm-specific predictions to create
a new prediction algorithm. We refer the reader to Polley et al. (2011) for further discussion of
Super Learner and its properties and to Naimi and Balzer (2018) for worked examples and R code.
The algorithm is available in the SuperLearner package in R (Polley et al., 2018).
The goal of Super Learner is to do the best possible job, according to the specified loss function,
of predicting the outcome Y , given the exposure A and covariates W , or predicting the exposure
A, given the covariates W . As a result, Super Learner-based estimators of the nuisance parameters
E(Y |A,W ) or P(A = 1|W ) have the wrong bias-variance tradeoff for our statistical estimand Ψ(P),
which is a single number as opposed to a whole prediction function. TMLE, discussed next, provides
one way to integrate data-adaptive algorithms, such as Super Learner, and still obtain the best
possible bias-variance tradeoff for the statistical estimand of interest. Indeed, a particular appeal of
the Targeted Learning framework is the use of flexible estimation methods to respect the statistical
model, which is often non-parametric, and to minimize the risk of bias due to regression model
misspecification.
Targeted Maximum Likelihood Estimation (TMLE) provides a general approach to con-
structing semi-parametric, efficient, substitution estimators (van der Laan and Rubin, 2006; van der
Laan and Rose, 2011; Petersen et al., 2014). Here, we provide a very brief overview and refer the
reader to Schuler and Rose (2017) for a thorough introduction to the algorithm, which is available
in the tmle, ltmle, and drtmle packages in R (Gruber and van der Laan, 2012; Lendle et al., 2017;
Benkeser et al., 2017). To implement TMLE for the G-computation identifiability result Ψ(P),
given in Equation 4, we take the following steps.
First, we use Super Learner provide an initial estimator of the conditional mean outcome, given
the exposure and covariates Eˆ0(Y |A,W ). Next, we “target” this initial estimator using information
from the propensity score Pˆ(A = 1|W ), also estimated with Super Learner. Informally, this targeting
step can be thought of as a second chance to control confounding and serves to reduce statistical bias
for the Ψ(P). We denote the updated estimator of the conditional mean outcome as Eˆ1(Y |A,W ) and
use it to obtain targeted predictions of the outcome setting the exposures of interest, but keeping
the covariates the same: Eˆ1(Yi|Ai = 1,Wi) and Eˆ1(Yi|Ai = 0,Wi) for all observations i = 1, . . . , N .
Finally, we obtain a point estimate by taking the average difference in these targeted predictions.
ΨˆTMLE(Pˆ) =
1
N
N∑
i=1
[
Eˆ1(Yi|Ai = 1,Wi)− Eˆ1(Yi|Ai = 0,Wi)
]
.
TMLE’s updating step also serves to endow the algorithm with a number of theoretical proper-
ties, which often translate into superior performance in finite samples. First, under regularity and
empirical process conditions detailed in van der Laan and Rose (2011), TMLE follows the Cen-
tral Limit Theorem and thus the normal distribution can be used for constructing 95% confidence
intervals and hypothesis testing, even if machine learning is used for estimation of the nuisance
parameters E(Y |A,W ) or P(A = 1|W ). Furthermore, the estimator is double robust in that it will
be consistent if either E(Y |A,W ) or P(A = 1|W ) is consistently estimated. Collaborative TMLE
further improves upon this robustness result (van der Laan and Gruber, 2010; Gruber and van der
Laan, 2015). Finally, if both nuisance parameters are estimated consistently and at fast enough
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rates, the estimator will be locally efficient and in large samples attain the minimal variance in a
semi-parametric statistical model. We refer the reader to Kennedy (2017) for an introduction to
semi-parametric, efficiency theory.
Finally, we note that there is nothing inherent in the TMLE algorithm that demands the use of
Super Learner. However, its implementation with machine learning algorithms avoids introducing
new unsubstantiated assumptions during estimation and improve our chances for consistent results.
Again, relying on misspecified parametric regressions can induce statistical bias and yield misleading
statistical inference.
2.7 Interpretation of Results
The final step of the Roadmap is to interpret our results. We have seen that the causal inference
framework clearly delineates the assumptions made from domain knowledge (Section 2.2) from
the ones desired for identifiability (Section 2.5). In other words, this framework ensures that
the assumptions needed to augment the statistical results with a causal interpretation are made
explicit. In this regard, Petersen and van der Laan (2014) argue for a hierarchy of interpretations
with “increasing strength of assumptions”. First, we always have a statistical interpretation as an
estimate of the difference in the expected outcome between exposed and unexposed units with the
same covariate values, standardized over the covariate distribution in the population. We can also
interpret Ψˆ(Pˆ) as an estimate of the marginal difference in the expected outcome associated with
the exposure, after controlling for measured confounding. To interpret our estimates causally, we
need the identifiability assumptions (Section 2.5) to hold in the original causal model (Section 2.2).
If either graphs in Figure 4 represented the true causal structure that generated our data and the
positivity assumption held, then we could interpret Ψˆ(Pˆ) as the average treatment effect or for a
binary outcome the causal risk difference.
Now, recall that the counterfactual outcomes were derived through intervening on the causal
model (Section 2.3). The selected intervention should match our underlying scientific question (Sec-
tion 2.1) and does not have to correspond to a feasible or realistic intervention. If the identifiability
assumptions (Section 2.5) held and the intervention could be conceivably implemented in the real
world, then we could further interpret Ψˆ(Pˆ) as an estimate of the intervention’s impact if it had been
implemented in the population of interest. Finally, if the identifiability assumptions were met and
the intervention implemented perfectly in a study sample, whose characteristics exactly matched
those of our population and who were fully measured, then we could interpret Ψˆ(Pˆ) as replicat-
ing the results of the randomized trial of interest. We note this hierarchy represents a divergence
from the Target Trial framework of Herna´n and Robins (2006), who suggest causal inference with
observational data can be thought of as “emulating” a randomized trial.
In our running example, the causal model shown in Figure 1 represents our knowledge of the
data generating process; there are measured (W1,W2) as well as unmeasured U common causes of
the exposure A and the outcome Y . Thus, the lack of identifiability prevents any interpretation
as a causal effect or further along the hierarchy. Thus, we can interpret a point estimate of Ψ(P)
as the difference in the probability of HIV RNA viral suppression associated with pregnancy after
controlling for the measured demographic and clinical confounders.
3 Conclusion
The objective of statistical analyses is to make inferences about the data generating process under-
lying a randomized trial or an observational study. In practice, statistical inference is concerned
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with purely data-driven tasks, such as prediction, estimation and hypothesis testing. In recent
decades, the advent of causal inference has triggered a shift in focus, particularly within the data
analysis community, toward a territory that has traditionally evaded statistical reach: the causal
mechanism underlying a data generating process. Statistical inference relies on patterns present in
the observed data, such as correlation, and therefore is unable, alone, to answer questions of causal
nature (Pearl, 2010; Pearl et al., 2016). Nonetheless, questions about cause and effect are of prime
importance in all fields including Data Science (Pearl, 2018; Herna´n et al., 2018).
We have presented an overview of one framework for causal inference. We emphasized how
the Causal Roadmap helps ensure consistency and transparency between the imperfect nature of
real world data, and the complexity associated with questions of causal nature. Of course, this
work serves only as a primer to causal inference in Data Science, and we have only presented the
fundamental concepts and tools in the causal inference arsenal.
Indeed, this framework can be extended to richer and more complicated questions. For instance,
our running example for average treatment effect only focused on a single exposure at a single time
point. However, as demonstrated in Tran et al. (2016); Kreif et al. (2017), the Causal Roadmap can
also handle multiple intervention nodes with time-dependent confounding. Other recent avenues of
research in causal inference are discussed in the Appendix.
As a final note, a Data Scientist may debate the usefulness of applying the causal inference
machinery to her own research. We hope to have clarified that if appropriately followed, the Causal
Roadmap forces us to think carefully about the goal of our research, the context in which data
were collected, and to explicitly define and justify any assumptions. It is our belief that conforming
to the rigors of this causal inference framework will improve the quality and reproducibility of all
scientific endeavors that rely on real data to understand how nature works.
Appendix
Here, we briefly highlight some extensions to more advanced settings. For each, we provide a broad
definition and a few examples with citations to some relevant works.
1. Marginal structural models provide a summary of how the distribution of the counter-
factual outcome changes as a function of the exposure and possibly pre-exposure covariates
(Robins, 1999; Robins et al., 2000; Bodnar et al., 2004; Neugebauer and van der Laan, 2007;
Robins and Herna´n, 2009; Petersen and van der Laan, 2011; Zheng et al., 2016). Marginal
structural models are another way to define our target causal parameter and especially useful
when the exposure is continuous or has many levels.
Examples: Robins et al. (2000) specified a logistic regression model to summarize the dose-
response relation for the cumulative effect of zidovudine (AZT) treatment on the counter-
factual risk of having undetectable HIV RNA levels among HIV-positive patients. For a
time-to-event outcome, Cole et al. (2012) used a Cox proportional hazard model to summa-
rize the association between treatment initiation and the counterfactual hazard of incident
AIDS or death among persons living with HIV.
2. Longitudinal exposures, corresponding to interventions on multiple treatment nodes, allow
us to assess the cumulative effect of an exposure or exposures over time (Robins et al., 2000;
Bang and Robins, 2005; Robins and Herna´n, 2009; Petersen and van der Laan, 2011; van der
Laan and Gruber, 2012; Westreich et al., 2012; Petersen et al., 2014). Examining the effects
of longitudinal exposures is complicated by time-dependent confounding, when a covariate
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is affected by a prior treatment and confounds a future treatment. In these settings, causal
frameworks have been especially useful for identifying the appropriate adjustment sets and
thereby statistical analysis.
Examples: Schnitzer et al. (2014) sought to assess the effect of breastfeeding duration on
gastrointestinal infections among new borns, while Decker et al. (2014) investigated the effects
of sustained physical activity and diet interventions on adolescent obesity.
3. Effect mediation refers to a general class of causal questions seeking to distinguish an ex-
posure’s direct effect on the outcome from its indirect effect through an intermediate variable
(Robins and Rotnitzky, 1992; Pearl, 2001; Petersen et al., 2006; van der Laan and Petersen,
2008; VanderWeele, 2009; Imai et al., 2010; Zheng and van der Laan, 2012; Tran et al., 2016).
There are several types of direct and indirect effects. For example, the controlled direct effect
refers to the contrast between the expected counterfactual outcomes under two levels of the
exposure, but when the mediator is fixed at a constant level. The natural direct effect, also
called the pure direct effect, refers to the contrast between the expected counterfactual out-
comes under two levels of the exposure, but when the mediator remains at its counterfactual
level under the reference value of the exposure. Indirect effects can be defined analogously.
Examples: Naimi et al. (2016) examined the disparity in infant mortality due to race that
would remain if all mothers breastfeed prior to hospital discharge. More recently, Rudolph
et al. (2018) investigated how the impact of neighborhood disadvantage on adolescent sub-
stance use was mediated by school and peer environment.
4. Dynamic treatment regimes are personalized rules for assigning the exposure or treatment
as a function of an individual’s covariate history (Murphy, 2003; Herna´n et al., 2006; van der
Laan and Petersen, 2007; Kitahata et al., 2009; Herna´n and Robins, 2009; Cain et al., 2010;
Kreif et al., 2017). They are also called “adaptive treatment strategies” and “individualized
treatment rules”. Static interventions, which assign a single level of the exposure to all
individuals regardless of their covariate values, can be considered a special case of dynamic
interventions.
Examples: Cain et al. (2010) and Young et al. (2011) both considered CD4-based thresholds
for initiating antiretroviral therapy and their impact on mortality among persons living with
HIV. Recently, Kreif et al. (2017) compared static and dynamic regimes to understand the
optimal timing and level of nutritional support for children in a pediatric intensive care unit.
5. Stochastic interventions aim to change or shift the distribution of the exposure (Korb et al.,
2004; Taubman et al., 2009; Cain et al., 2010; Dı´az and van der Laan, 2012, 2013b; Rudolph
et al., 2017). Stochastic interventions are especially useful when the exposure of interest can
not be directly manipulated and can help alleviate violations to the positivity assumption.
Deterministic interventions, which assign a given level of the exposure with probability one,
can be considered a special case of stochastic interventions.
Examples : Dı´az and van der Laan (2012) asked what is the impact of a policy encouraging
more exercise, according to health and socioeconomic factors, on mortality in a population of
older adults? Danaei et al. (2013) examined the impact of various lifestyle interventions, such
as eating at least 2 servings of whole grain per day, on the risk of type 2 diabetes in women.
6. Clustered data occur when there is dependence or correlation between individuals within
some grouping, such as a clinic, school, neighborhood, or community. Such correlation can
arise from shared cluster-level factors, including the exposure, and from social or biological
interactions between individuals with a cluster (Halloran and Struchiner, 1991, 1995; Oakes,
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2004; Tchetgen Tchetgen and VanderWeele, 2012; van der Laan, 2014; Schnitzer et al., 2014;
Prague et al., 2016; Balzer et al., 2018; Morozova et al., 2018; Buchanan et al., 2018). This
dependence must be accounted when specifying the causal model and often demands relaxing
the stable unit treatment value assumption, which prohibits one unit’s exposure from impact-
ing another’s outcome (Rubin, 1978).
Examples: Balzer et al. (2018) examined the impact of household socioeconomic status, a
cluster-level variable, on the risk of failing to test for HIV. Likewise, Buchanan et al. (2018)
investigated both the individual and disseminated effects of a network-randomized interven-
tion among people who inject drugs.
7. Missing data, censoring, and losses to follow up can all be treated as additional inter-
vention nodes in a given causal framework (Robins et al., 2000, 1994; Scharfstein et al., 1999;
Daniel et al., 2012; Mohan et al., 2013; Balzer et al., 2017). Thereby, we can treat missing
data as a causal inference problem - as opposed to causal inference as a missing data.
Examples : When estimating the effect of iron supplementation during pregnancy on anemia
at delivery, Bodnar et al. (2004) used inverse probability of censoring weights to adjust for
the measured ways in which the women who were censored could differ from those who were
not. Likewise, Petersen et al. (2017) estimated the probability of HIV RNA viral suppression
over time among a closed cohort of HIV-infected adults, under a hypothetical intervention to
prevent censoring and ensure complete viral load measurement.
8. Transportability, a subset of generalizability, aims to apply the effect for a given sample
to a different population or setting (Cole and Stuart, 2010; Stuart et al., 2011; Herna´n and
VanderWeele, 2011; Petersen, 2011; Bareinboim and Pearl, 2013; Pearl, 2015; Lesko et al.,
2017; Balzer, 2017).
Examples: Rudolph and van der Laan (2017) examined whether the reduction in school
dropout observed in the Moving to Opportunity trial was consistent between Boston and Los
Angeles. Recently, Hong et al. (2018) investigated whether the reductions in cardiovascular
risk from rosuvastatin as observed in the JUPITER trial would also have been observed in
the UK population who were trial eligible.
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